ARCHIVES

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

FDA Designates Zometa For Priority Review.

November 30, 2001

Declining Support Among Oncologists For Euthanasia.

October 13, 2000

DCT To Examine Groups’ Studies, Directions, Role in 2000 A.D. Goal

June 8, 1984

IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk.

June 29, 2001

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

October 3, 1997